We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.03%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.17B
AUM Growth
-$6.39M
Cap. Flow
+$112M
Cap. Flow %
5.16%
Top 10 Hldgs %
36.67%
Holding
3,684
New
390
Increased
1,388
Reduced
1,049
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 12.44%
2 Healthcare 9.68%
3 Financials 8.68%
4 Consumer Discretionary 4.31%
5 Communication Services 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KBAL
3551
DELISTED
Kimball International
KBAL
$0 ﹤0.01%
30
+5
+20% +$39
BLCM
3552
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$0 ﹤0.01%
10
MGI
3553
DELISTED
MoneyGram International, Inc. New
MGI
$0 ﹤0.01%
18
ARVL
3554
DELISTED
Arrival Ordinary Shares
ARVL
$0 ﹤0.01%
8
DCT
3555
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$0 ﹤0.01%
+22
New +$291
SGFY
3556
DELISTED
Signify Health, Inc.
SGFY
$0 ﹤0.01%
+7
New +$161
EVOP
3557
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$0 ﹤0.01%
+8
New +$247
LYLT
3558
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$0 ﹤0.01%
+124
New +$322
VVNT
3559
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
-35
Closed
GET
3560
DELISTED
Getnet Adquirencia e Servicos para Meios de Pagamento S.A. American Depositary Shares
GET
$0 ﹤0.01%
1
ALBO
3561
DELISTED
Albireo Pharma Inc
ALBO
-9
Closed
LCI
3562
DELISTED
Lannett Company, Inc.
LCI
$0 ﹤0.01%
+40
New +$88
CLVS
3563
DELISTED
Clovis Oncology, Inc.
CLVS
$0 ﹤0.01%
100
AKUS
3564
DELISTED
Akouos Inc
AKUS
$0 ﹤0.01%
10
AERI
3565
DELISTED
Aerie Pharmaceuticals
AERI
$0 ﹤0.01%
+8
New +$93
FSRD
3566
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
$0 ﹤0.01%
500
ZVO
3567
DELISTED
Zovio Inc. Common Stock
ZVO
$0 ﹤0.01%
179
FMTX
3568
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$0 ﹤0.01%
+6
New +$79
TGA
3569
DELISTED
Transglobe Energy Corp
TGA
-242
Closed -$1K
HYT.RT
3570
DELISTED
BlackRock Corporate High Yield Fund, Inc. Rights (expiring October 13, 2022)
HYT.RT
$0 ﹤0.01%
+17,079
New +$97
GBT
3571
DELISTED
Global Blood Therapeutics, Inc.
GBT
$0 ﹤0.01%
+2
New +$110
BRG
3572
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$0 ﹤0.01%
+10
New +$263
HNGR
3573
DELISTED
Hanger Inc.
HNGR
$0 ﹤0.01%
+15
New +$266
MANT
3574
DELISTED
Mantech International Corp
MANT
-222
Closed -$21K
CTT
3575
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
-540
Closed -$5K

Similar funds

Parallel Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Parallel Advisors held 3,684 positions worth $2.17B, down 0.29% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $112M of net new capital in Q3 2022, opening 390 new positions and adding to 1,388 existing holdings. Its largest new stake was iShares MSCI USA Equal Weighted ETF: 17,208 shares worth $1.15M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $24.4M trimmed.

  • Parallel Advisors's largest Q3 2022 buy was iShares MSCI USA Equal Weighted ETF: 17,208 shares worth $1.15M.
  • Parallel Advisors added most to iShares International Select Dividend ETF in Q3 2022, an estimated $42.9M increase.
  • Parallel Advisors's biggest Q3 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $24.4M.
  • Parallel Advisors fully exited Sanderson Farms Inc in Q3 2022, selling an estimated $503K.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.17B portfolio in Q3 2022.
  • Parallel Advisors opened 390 new positions and closed 222 in Q3 2022.
  • Parallel Advisors's portfolio value fell 0.29% quarter-over-quarter to $2.17B.

Based on Parallel Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.